Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
ZAC 166
Key Takeaways
Risk factor
Very high price volatility
Data is available to registered users only
Data is available to registered users only
Profitability factor
Undervalued vs peers
Data is available to registered users only
Data is available to registered users only
About
RH Bophelo Limited invests in healthcare sector in South Africa. It primarily invests in equity, quasi-equity, and equity related investments in operational infrastructure, including health insurance, private hospital-related infrastructure, pharmaceuticals, and retail and distribution sectors. The company was incorporated in 2016 and is based in Johannesburg, South Africa. RH Bophelo Limited is a subsidiary of Public Investment Corporation SOC Limited.
Company Valuation
Considering past and projected metrics, the stock is 'cheaper' than its peers. Specifically, the stock is 'cheap' on P/E, undervalued on EV/EBITD.
Data is available to registered users only
Buy
Sell